Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
Tel: |
15076683720 |
Email: |
klq@cw-bio.com |
Products Intro: |
Product Name:(E/Z)-ZINC09659342 CAS:591726-26-0 Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Email: |
sales@dcchemicals.com |
Products Intro: |
Product Name:(E/Z)-ZINC09659342 CAS:591726-26-0 Purity:98% HPLC Package:100mg,250mg,1g
|
Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
Tel: |
021-65675885 18964387627 |
Email: |
customer_service@efebio.com |
Products Intro: |
Product Name:(E/Z)-ZINC09659342 CAS:591726-26-0 Purity:95.00% Package:1mg;5mg;10mg
|
|
| Benzoic acid, 4-[4,5-dihydro-3-methyl-5-oxo-4-[[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methylene]-1H-pyrazol-1-yl]- Basic information |
Product Name: | Benzoic acid, 4-[4,5-dihydro-3-methyl-5-oxo-4-[[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methylene]-1H-pyrazol-1-yl]- | Synonyms: | Benzoic acid, 4-[4,5-dihydro-3-methyl-5-oxo-4-[[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methylene]-1H-pyrazol-1-yl]-;(E/Z)-ZINC09659342;(E/Z)-ZINC09659342,Inhibitor,Lbc-RhoA interaction,Ras,(E/Z)ZINC09659342,Ras superfamily,inhibit,(E/Z) ZINC09659342 | CAS: | 591726-26-0 | MF: | C23H15F3N2O4 | MW: | 440.37 | EINECS: | | Product Categories: | | Mol File: | 591726-26-0.mol | |
| Benzoic acid, 4-[4,5-dihydro-3-methyl-5-oxo-4-[[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methylene]-1H-pyrazol-1-yl]- Chemical Properties |
Boiling point | 594.2±60.0 °C(Predicted) | density | 1.39±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | form | Solid | pka | 4.20±0.10(Predicted) | color | Orange to red |
| Benzoic acid, 4-[4,5-dihydro-3-methyl-5-oxo-4-[[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methylene]-1H-pyrazol-1-yl]- Usage And Synthesis |
Biological Activity | (E/Z)-ZINC09659342 is an inhibitor of Lbc-RhoA interaction[1]. | References | [1]. Francesca FANELLI, et al. Compounds and composition for use in the inhibition of the lbc-rhoa interaction, in particular for the treatment of cancer. WO2015028929A1. |
| Benzoic acid, 4-[4,5-dihydro-3-methyl-5-oxo-4-[[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methylene]-1H-pyrazol-1-yl]- Preparation Products And Raw materials |
|